rho kinase inhibitor Search Results


rockout  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology rockout
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rockout, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/Rho+Kinase+Inhibitor/bio_rxiv__2021__03__27__437282-61-0-5
Average 92 stars, based on 1 article reviews
rockout - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
rock inhibitor iii  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology rock inhibitor iii
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rock Inhibitor Iii, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/Rho+Kinase+Inhibitor+III%2C+Rockout/pmc06504901-85-0-4
Average 93 stars, based on 1 article reviews
rock inhibitor iii - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
pyridyl n  (Santa Cruz Biotechnology)
85
Santa Cruz Biotechnology pyridyl n
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Pyridyl N, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/Rho+Kinase+Inhibitor+II/us11999971-912-72-94
Average 85 stars, based on 1 article reviews
pyridyl n - by Bioz Stars, 2026-09
85/100 stars
  Buy from Supplier
rho kinase inhibitor  (ReproCELL)
94
ReproCELL rho kinase inhibitor
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Kinase Inhibitor, supplied by ReproCELL, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/Stemolecule+Y27632+in+Solution/pmc11215757-83-0-3
Average 94 stars, based on 1 article reviews
rho kinase inhibitor - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
rho kinase inhibitor iv  (Santa Cruz Biotechnology)
85
Santa Cruz Biotechnology rho kinase inhibitor iv
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Kinase Inhibitor Iv, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/Rho+Kinase+Inhibitor+IV/10__1091_slash_mbc__e15___01___0003-200-100-63
Average 85 stars, based on 1 article reviews
rho kinase inhibitor iv - by Bioz Stars, 2026-09
85/100 stars
  Buy from Supplier
rock inhibitor  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology rock inhibitor
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rock Inhibitor, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/Rho+Kinase+Inhibitor+V/pmc04903018-103-23-25
Average 93 stars, based on 1 article reviews
rock inhibitor - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
rho-associated protein kinase (rock)-inhibitor  (ReproCELL)
90
ReproCELL rho-associated protein kinase (rock)-inhibitor
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Associated Protein Kinase (Rock) Inhibitor, supplied by ReproCELL, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/rho+associated+protein+kinase++rock++inhibitor/pm27096366-314-11-18
Average 90 stars, based on 1 article reviews
rho-associated protein kinase (rock)-inhibitor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rho kinase-specific inhibitor y-27632  (SLIT2 LTD)
90
SLIT2 LTD rho kinase-specific inhibitor y-27632
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Kinase Specific Inhibitor Y 27632, supplied by SLIT2 LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/rho+kinase+specific+inhibitor+y+27632/10__1074_slash_jbc__m111__317610-188-9-22
Average 90 stars, based on 1 article reviews
rho kinase-specific inhibitor y-27632 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rho kinase inhibitors  (Bioaxone Inc)
90
Bioaxone Inc rho kinase inhibitors
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Kinase Inhibitors, supplied by Bioaxone Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/rho+kinase+inhibitors/pm22222285-1056-4-5
Average 90 stars, based on 1 article reviews
rho kinase inhibitors - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
y-27632 rho kinase inhibitor  (Lucerna-Chem ag)
90
Lucerna-Chem ag y-27632 rho kinase inhibitor
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Y 27632 Rho Kinase Inhibitor, supplied by Lucerna-Chem ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/y+27632+rho+kinase+inhibitor/pm37114406-143-10-15
Average 90 stars, based on 1 article reviews
y-27632 rho kinase inhibitor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rho-kinase (rock) inhibitor  (Merck KGaA)
90
Merck KGaA rho-kinase (rock) inhibitor
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Kinase (Rock) Inhibitor, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/rho+kinase++rock++inhibitor/pmc09282930-262-2-5
Average 90 stars, based on 1 article reviews
rho-kinase (rock) inhibitor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
rho kinase inhibitor  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics rho kinase inhibitor
( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor <t>(Rockout)-treated</t> 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.
Rho Kinase Inhibitor, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rho+kinase+inhibitor/rho+kinase+inhibitor/us11767508-20-80-116
Average 90 stars, based on 1 article reviews
rho kinase inhibitor - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor (Rockout)-treated 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.

Journal: bioRxiv

Article Title: In vivo dissection of Rhoa function in vascular development using zebrafish

doi: 10.1101/2021.03.27.437282

Figure Lengend Snippet: ( A-D ) Whole-mount in situ hybridization analyses of 48 hpf wild type zebrafish embryos probed for rock1 (A,B) or rock2a (C,D) gene expression. (A,C) Lateral views, anterior to left. (B,D) Higher magnification dorsal views of the heads shown in panels A,C. ( E,G,I,K ) Stereoscope transmitted light images of DMSO-treated control sibling (E,I) or 25 μM (G) or 50 μM (K) Rock1/2 inhibitor (Rockout)-treated 50 hpf Tg(kdrl:EGFP), Tg(gata1a:DsRed) embryos. Arrowheads indicate hemorrhage. ( F,H,J,L ) Confocal images of cranial vessels (EGFP-positive, green) and blood cells (DsRed-positive, magenta) in the same embryos shown in panels E,G,I,K. Arrows indicate CtA defects, arrowheads indicate hemorrhage. ( M,N ) Quantitation of the percentage of 52 hpf Rockout-treated (light grey columns) or DMSO-treated (dark grey columns) sibling embryos with cranial hemorrhage (M) or cranial CtA defects (N). * P < 0.0001 compared to DMSO-treated controls, by Cochran-Mantel-Haenszel test. Mean ± SD is shown for each graph.

Article Snippet: Rockout (Rho Kinase Inhibitor III; Santa Cruz Biotechnology) was used to inhibit Rock1/2 activity .

Techniques: In Situ Hybridization, Gene Expression, Control, Quantitation Assay